Grantham, Mayo, Van Otterloo & Co (GMO)’s CSX Corp CSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.14M Sell
149,693
-91,782
-38% -$3.6M 0.02% 290
2025
Q4
$8.75M Sell
241,475
-98,157
-29% -$3.51M 0.02% 253
2025
Q3
$12.1M Buy
339,632
+312,210
+1,139% +$10.7M 0.03% 221
2025
Q2
$895K Sell
27,422
-22,104
-45% -$665K ﹤0.01% 493
2025
Q1
$1.46M Sell
49,526
-14,606
-23% -$464K ﹤0.01% 395
2024
Q4
$2.07M Sell
64,132
-9,471
-13% -$325K 0.01% 374
2024
Q3
$2.54M Buy
73,603
+8,275
+13% +$281K 0.01% 357
2024
Q2
$2.19M Buy
65,328
+59,124
+953% +$2.01M 0.01% 362
2024
Q1
$230K Buy
+6,204
New +$226K ﹤0.01% 488
2017
Q4
Sell
-1,224,900
Closed -$22.2M 588
2017
Q3
$22.2M Sell
1,224,900
-161,400
-12% -$2.77M 0.13% 108
2017
Q2
$25.2M Buy
1,386,300
+505,500
+57% +$8.66M 0.14% 112
2017
Q1
$13.7M Buy
+880,800
New +$13.4M 0.08% 166

Other funds holding CSX

Grantham, Mayo, Van Otterloo & Co (GMO)'s CSX Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its CSX Corp (CSX) stake by 38% in Q1 2026, selling an estimated $3.6M and leaving 149,693 shares worth $6.14M. The position accounts for 0.02% of the portfolio, ranked #290.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CSX in Q1 2017 and has held it in 12 quarters since. The position peaked at $25.2M in Q2 2017. 1,863 funds tracked by Wall St. Rank hold CSX as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 149,693 shares of CSX Corp worth $6.14M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 91,782 CSX Corp shares in Q1 2026, an estimated $3.6M.
  • CSX Corp made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #290 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CSX Corp in Q1 2017 and has held it in 12 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CSX Corp position peaked at $25.2M in Q2 2017.
  • 1,863 funds tracked by Wall St. Rank held CSX Corp as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.